126 related articles for article (PubMed ID: 34971072)
1. Malignant extracranial germ cell tumours: A first national report by the South African Children's Cancer Study Group.
Hendricks M; Cois A; Geel J; du Plessis J; Bassingthwaighte M; Naidu G; Rowe B; Büchner A; Omar F; Thomas K; Uys R; van Zyl A; van Heerden J; Mahlachana N; Vermeulen J; Davidson A; Frazier AL; Donald K; Kruger M
Pediatr Blood Cancer; 2022 May; 69(5):e29543. PubMed ID: 34971072
[TBL] [Abstract][Full Text] [Related]
2. Extracranial germ cell tumours: Mature and immature (1990-2015). First report by the South African Association of Paediatric Haematology Oncology (SAAPHO).
Hendricks M; Cois A; Geel J; van Heerden J; Naidu G; Plessis JD; van Zyl A; Bassingthwaighte M; Omar F; Büchner A; Rowe B; Thomas K; Uys R; Mahlachana N; Davidson A; Frazier L AL; Donald KA; Kruger M M
Pediatr Blood Cancer; 2024 Jan; 71(1):e30723. PubMed ID: 37872125
[TBL] [Abstract][Full Text] [Related]
3. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII).
Depani S; Stoneham S; Krailo M; Xia C; Nicholson J
Eur J Cancer; 2019 Sep; 118():49-57. PubMed ID: 31306943
[TBL] [Abstract][Full Text] [Related]
4. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
5. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
Frazier AL; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray MJ; Amatruda JF; Thornton C; Arul GS; Billmire D; Shaikh F; Pashankar F; Stoneham S; Krailo M; Nicholson JC
J Clin Oncol; 2015 Jan; 33(2):195-201. PubMed ID: 25452439
[TBL] [Abstract][Full Text] [Related]
6. Malignant sacrococcygeal germ cell tumors in children: a 30-year experience from a single institution.
Büyükpamukçu M; Varan A; Küpeli S; Ekinci S; Yalcin S; Kale G; Yalçin B; Kutluk T; Akyüz C
Tumori; 2013; 99(1):51-6. PubMed ID: 23549000
[TBL] [Abstract][Full Text] [Related]
7. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
8. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
9. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
[TBL] [Abstract][Full Text] [Related]
10. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
[TBL] [Abstract][Full Text] [Related]
11. α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium.
O'Neill AF; Xia C; Krailo MD; Shaikh F; Pashankar FD; Billmire DF; Olson TA; Amatruda JF; Villaluna D; Huang L; Malogolowkin M; Rodriguez-Galindo C; Frazier AL
Cancer; 2019 Oct; 125(20):3649-3656. PubMed ID: 31355926
[TBL] [Abstract][Full Text] [Related]
12. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract][Full Text] [Related]
13. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.
Frazier AL; Stoneham S; Rodriguez-Galindo C; Dang H; Xia C; Olson TA; Murray MJ; Amatruda JF; Shaikh F; Pashankar F; Billmire D; Krailo M; Stark D; Brougham MFH; Nicholson JC; Hale JP
Eur J Cancer; 2018 Jul; 98():30-37. PubMed ID: 29859339
[TBL] [Abstract][Full Text] [Related]
14. Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol.
Faure-Conter C; Orbach D; Sudour-Bonnange H; Verité C; Mansuy L; Rome A; Dumesnil C; Thebaud E; Renard M; Hameury F; Flechon A; Blanc E; Dijoud F; Fresneau B; Chabaud S
Pediatr Blood Cancer; 2023 Mar; 70(3):e30117. PubMed ID: 36451268
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and prognostic variables of extracranial germ cell tumors in children and adolescents treated over a decade: A developing world perspective.
Ramanathan S; Prasad M; Vora T; Parambil BC; Kembhavi S; Ramadwar M; Khanna N; Laskar S; Kurkure P; Qureshi S; Banavali S; Chinnaswamy G
Pediatr Blood Cancer; 2022 Jul; 69(7):e29765. PubMed ID: 35561025
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
17. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: First report by the South African Children's Cancer Study Group.
Geel JA; Chirwa TC; Rowe B; Eyal KC; Omar F; Stones DK; Goga Y; Stefan DC; van Zyl A; Van Emmenes B; Wedi O; Vaithilingum M; Hendricks MG;
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28383768
[TBL] [Abstract][Full Text] [Related]
20. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
